We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Pioneering Radiotherapy Technology Treats Multiple Brain Metastases

By HospiMedica International staff writers
Posted on 15 Sep 2008
An innovative radiosurgery system targets treatment beams at tumors while rotating continuously around the patient, makes it possible to complete stereotactic radiosurgery sessions many times faster than conventional techniques that use stationary beams.

The Varian RapidArc stereotactic radiosurgery system is a volumetric arc therapy device that delivers a precisely sculpted three-dimensional (3D) dose distribution with a single 360o rotation of the linear accelerator gantry. More...
It is made possible by a treatment planning algorithm that simultaneously changes three parameters during treatment; leaf interdigitation using a multileaf collimator (MLC), a dynamic "sliding window” approach to beam-shaping, and a patented "gridded gun” to vary the dose rate as a function of the gantry angle.

As a result, a single arc can deliver essentially similar dose distributions compared with intensity-modulated radiation therapy (IMRT) treatment plans that incorporate as many as 36 fields while delivering therapeutic radiation doses to the whole volume of the tumor, rather than slice by slice. Additionally, the treatment-planning algorithm ensures enhanced precision, helping to spare normal healthy tissue. The Varian RapidArc stereotactic radiosurgery system is a product of Varian Medical Systems (Palo Alto, CA, USA).

Researchers from Vrije Universiteit (VU) Medical Center (VUMC; Amsterdam, The Netherlands) began clinical treatments using volumetric modulated arc therapy with the RapidArc in early May 2008 and more than 20 patients have so far been treated. RapidArc was first used to replace IMRT treatments for head and neck, brain, and prostate tumors but from September 2008 onwards RapidArc will replace all conventional treatments at VUMC, since treatments were found to be two to eight times faster than IMRT. VUMC studies with the system were presented at the American Association of Physics in Medicine (AAPM) meeting, held in Houston (TX, USA) in July 2008.

"Our experiences to date have demonstrated that RapidArc appears to be excellent for stereotactic radiosurgery,” said Frank Lagerwaard, M.D., of the department of radiation oncology. "The total time needed for patients to enter and leave the treatment room has decreased to less than 15 minutes as we gain experience. During these treatments the delivery time was just 210 seconds per session.”

By comparison, conventional IMRT stereotactic treatment of three brain metastases using multiple dynamic conformal arcs takes more than 50 minutes from first beam on to last beam off.

Related Links:
Varian Medical Systems
VU medical center


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.